US Pharma MarketingRadiopharmaceutical outfit Lantheus mulls potential $7B takeover by Curium: Bloomberg
Radiopharmaceutical outfit Lantheus mulls potential $7B takeover by Curium: Bloomberg is a pharma and life sciences industry update from FiercePharma. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
The potential $7 billion buyout deal in the radiopharmaceutical space could be weeks away, Bloomberg reported, citing people familiar with the matter.
Source: FiercePharma